Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,307 | 16,393 | 6,678 | 50,611 | 65,300 |
| Receivables | 1,261 | 2,471 | 290 | 2,160 | 3,675 |
| Inventories | 1,307 | 2,691 | 4,009 | 229 | 73 |
| Other current assets | 37 | 0 | 0 | 0 | 0 |
| TOTAL | $11,500 | $23,981 | $11,267 | $55,488 | $70,820 |
| Non-Current Assets | |||||
| PPE Net | 9,806 | 10,966 | 11,645 | 216 | 192 |
| Investments And Advances | 0 | 0 | 743 | 0 | 0 |
| Intangibles | 0 | 0 | 7 | 0 | 8,755 |
| Other Non-Current Assets | 125 | 123 | 83 | 322 | 335 |
| TOTAL | $9,931 | $11,089 | $12,478 | $538 | $9,282 |
| Total Assets | $21,431 | $35,070 | $23,745 | $56,026 | $80,102 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,883 | 4,730 | 1,012 | 3,828 | 2,672 |
| Other current liabilities | 1,393 | 1,996 | N/A | 45 | 34 |
| TOTAL | $3,613 | $7,222 | $1,311 | $7,044 | $7,766 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 120 | N/A | 2,949 | 4,815 |
| Other Non-Current Liabilities | 12,918 | 13,773 | 1,399 | 11,412 | 17,759 |
| TOTAL | $13,976 | $14,687 | $1,399 | $13,206 | $19,350 |
| Total Liabilities | $17,589 | $21,909 | $2,710 | $20,250 | $27,116 |
| Shareholders' Equity | |||||
| Common Shares | 22,624 | 22,486 | 13,517 | 293,410 | 293,410 |
| Retained earnings | -20,508 | -12,110 | 4,356 | -352,084 | -334,619 |
| Other shareholders' equity | -2,444 | -1,483 | -712 | 4,118 | 94,195 |
| TOTAL | $3,842 | $13,161 | $21,035 | $35,776 | $52,986 |
| Total Liabilities And Equity | $21,431 | $35,070 | $23,745 | $56,026 | $80,102 |